We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-16.54%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$830M
AUM Growth
-$565M
Cap. Flow
-$326M
Cap. Flow %
-39.23%
Top 10 Hldgs %
32.51%
Holding
388
New
137
Increased
33
Reduced
55
Closed
151

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$240M
2
FIVE icon
Five Below
FIVE
+$22.2M
3
VRT icon
Vertiv
VRT
+$17.8M
4
BBWI icon
Bath & Body Works
BBWI
+$14.2M
5
CWH icon
Camping World
CWH
+$13.6M

Sector Composition

Rank Sector Weight
1 Consumer Staples 13.75%
2 Consumer Discretionary 13.7%
3 Industrials 7.8%
4 Healthcare 6.84%
5 Technology 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMH icon
201
VanEck Semiconductor ETF
SMH
$68.5B
$280K 0.03%
4,784
-23,928
-83% -$1.61M
MLCO icon
202
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
$277K 0.03%
+22,300
New +$426K
TGTX icon
203
TG Therapeutics
TGTX
$7.07B
$273K 0.03%
+27,783
New +$351K
QQQ icon
204
Invesco QQQ Trust
QQQ
$469B
$257K 0.03%
1,349
-12,870
-91% -$2.72M
ITB icon
205
iShares US Home Construction ETF
ITB
$2.25B
$251K 0.03%
+8,661
New +$371K
NTR icon
206
Nutrien
NTR
$31.7B
$247K 0.03%
7,263
-34,057
-82% -$1.36M
ITA icon
207
iShares US Aerospace & Defense ETF
ITA
$14.4B
$236K 0.03%
+3,284
New +$336K
NXTC icon
208
NextCure
NXTC
$17.9M
$228K 0.03%
512
-30
-6% -$16K
TPST icon
209
CALL
Tempest Therapeutics
TPST
$14M
$212K 0.03%
+205
New +$299K
TXMD icon
210
CALL
TherapeuticsMD
TXMD
$23.6M
$212K 0.03%
4,000
DHT icon
211
DHT Holdings
DHT
$2.98B
$211K 0.03%
27,527
+15,779
+134% +$100K
PII icon
212
Polaris
PII
$4.02B
$200K 0.02%
+4,162
New +$341K
PINS icon
213
Pinterest
PINS
$13.5B
$200K 0.02%
+12,954
New +$252K
PRVB
214
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$184K 0.02%
19,999
-23,661
-54% -$305K
WSG
215
DELISTED
Wanda Sports Group Company Limited American Depositary Shares
WSG
$182K 0.02%
+78,627
New +$238K
ARKO icon
216
CALL
ARKO Corp
ARKO
$851M
$179K 0.02%
166,666
EAT icon
217
PUT
Brinker International
EAT
$9.66B
$178K 0.02%
+14,800
New +$498K
EAT icon
218
Brinker International
EAT
$9.66B
$177K 0.02%
+14,766
New +$497K
YARW
219
CALL
Yarrow Bioscience, Inc. Common Stock
YARW
$22.4M
$158K 0.02%
+16
New +$251K
DVN icon
220
Devon Energy
DVN
$51.4B
$154K 0.02%
+22,222
New +$402K
CGEN icon
221
Compugen
CGEN
$225M
$145K 0.02%
+20,000
New +$157K
ADV icon
222
CALL
Advantage Solutions
ADV
$527M
$130K 0.02%
4,634
+4,000
+631% +$1.08M
VNTR
223
DELISTED
Venator Materials PLC
VNTR
$127K 0.02%
73,929
+7,094
+11% +$20K
CMBT
224
CMB.TECH NV
CMBT
$4.72B
$125K 0.02%
+11,112
New +$115K
PHGE icon
225
CALL
BiomX
PHGE
$2.01M
$98K 0.01%
789

Similar funds

J. Goldman & Co's Q1 2020 Portfolio in Review

As of Q1 2020, J. Goldman & Co held 388 positions worth $830M, down 41% from $1.39B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

J. Goldman & Co withdrew a net $326M in Q1 2020, closing 151 positions and reducing 55 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, J. Goldman & Co opened a new position in Dollar Tree worth $24.2M.

  • J. Goldman & Co's largest Q1 2020 buy was Dollar Tree: 329,538 shares worth $24.2M.
  • J. Goldman & Co added most to State Street Consumer Staples Select Sector SPDR ETF in Q1 2020, an estimated $10.7M increase.
  • J. Goldman & Co's biggest Q1 2020 reduction was Bath & Body Works, cutting an estimated $14.2M.
  • J. Goldman & Co fully exited iShares Core S&P 500 ETF in Q1 2020, selling an estimated $240M.
  • J. Goldman & Co's ten largest holdings make up 33% of its $830M portfolio in Q1 2020.
  • J. Goldman & Co opened 137 new positions and closed 151 in Q1 2020.
  • J. Goldman & Co's portfolio value fell 41% quarter-over-quarter to $830M.

Based on J. Goldman & Co's 13F filing for Q1 2020, filed 15 May 2020.